금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Nasdaq raises red flag on 3 overnight risks ahead of Dec. 6 — and they pose an extra-big threat to retirement nest eggs
Extended 23-hour trading starts Dec. 6 — and thin overnight liquidity can devastate retirees' nest e...
‘Non-answers’ aren’t working. This is what investors really need from the Fed.
What really matters to investors, economists say, is for Fed Chairman Kevin Warsh to prove he can su...
3 Reasons to Sell SWKS and 1 Stock to Buy Instead
Skyworks Solutions currently trades at $65.78 per share and has shown little upside over the past six months, posting a middling return of 2.1%. The stock also fell short of the S&P 500’s 9.3% gain du ...
3 Reasons to Avoid FBIN and 1 Stock to Buy Instead
Fortune Brands trades at $54.13 and has moved in lockstep with the market. Its shares have returned 6.3% over the last six months while the S&P 500 has gained 9.3%.
3 Reasons to Avoid MTCH and 1 Stock to Buy Instead
Over the past six months, Match Group has been a great trade, beating the S&P 500 by 11%. Its stock price has climbed to $38.20, representing a healthy 20.3% increase. This was partly due to its solid ...
Silicom falls 10% despite analyst upgrade after AI-driven rally
Merger Value Hit a First-Half Record as Deal Sizes Grew
Global merger activity reached a record $2.6 trillion in the first half of the year as companies pursued larger acquisitions, while analysts expect dealmaking to broaden into smaller companies.
Concerts are increasingly for superfans and the rich, analysts say
Some arenas are devoting nearly a third of their space to premium seats and services.
Veracyte Stock Surges 117% in a Year: What's Driving the Rally?
VCYT's 117% stock surge is driven by durable growth plans, Afirma demand, TrueMRD progress, international IVD efforts and a debt-free balance sheet.
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook.
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.
Inter CFO talks Rule of 50, U.S. expansion: says discipline is paying off
Investing.com -- Four years after listing on the NASDAQ with a bet that disciplined, profitable growth would outlast fintech’s growth-at-all-costs model, Inter & Co. believes that bet is paying off, a ...
Microsoft merging enterprise, consumer Copilot AI chatbots: report
Sector Update: Energy Stocks Advance Thursday Afternoon
Energy stocks were higher Thursday afternoon, with the NYSE Energy Sector Index rising 0.9% and the